HUTCHMED (China) (HMDCF) Buildings (2015 - 2016)
HUTCHMED (China)'s (HMDCF) quarterly Buildings came in at $2.3 million in Q2 2016, down 2.51% quarter-over-quarter from $2.4 million in Q4 2015.
Powered by 
Analysis
HUTCHMED (China) (HMDCF) Buildings (2015 - 2016) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Buildings for 2 consecutive years, with $2.3 million the latest figure, recorded in Q2 2016.
- On a quarterly basis, Buildings changed N/A year-over-year to $2.3 million in Q2 2016; TTM through Jun 2016 was $2.3 million, a N/A change from a year earlier, with the FY2015 full-year figure at $2.4 million, changed N/A from the prior year.
- Buildings was $2.3 million for Q2 2016 at HUTCHMED (China), down from $2.4 million in the prior quarter.
- Over five years, Buildings peaked at $2.4 million in Q4 2015 and troughed at $2.3 million in Q2 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.55 Bn | 197.56 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.17 Bn | 177.99 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.18 Bn | 124.33 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.50 Bn | 74.50 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.66 Bn | 56.48 Bn | 1.37 Bn |
| 6 | Moderna | 54.61 Bn | 49.47 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.17 Bn | 30.86 Bn | 992.69 Mn |
| 8 | Biogen | 31.36 Bn | 30.07 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.04 Bn | 30.04 Bn | 1.16 Mn |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - |